Brief: Tivic Health Systems Q3 Net Income USD -1.431 Million
15/11/2024 04:36
Nov 15 (Reuters) - Tivic Health Systems Q3 revenue USD 126 thousand. * Q3 operating expenses USD 1.475 million * Q3 operating income USD -1.431 million * Q3 gross profit USD 44 thousand * Q3 basic EPS USD -0.23
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital